Trazodone Cost in Nevada (2026): Cash Prices, Insurance, Medicaid, and Savings

At a glance
- Average Nevada cash price / approximately $10 per month for generic trazodone (2026)
- Manufacturer list price (generic) / around $40 per month before discounts
- Nevada Medicaid status / not on the preferred drug list; prior authorization may be required
- Telehealth prescribing in NV / permitted under Nevada telemedicine statutes
- Compounded trazodone / available through licensed 503A pharmacies in Nevada
- Most common dose / 50 to 100 mg oral tablet taken once at bedtime for sleep
- FDA-approved indication / major depressive disorder (off-label use for insomnia is widespread)
- Tier placement on most commercial plans / Tier 1 (preferred generic)
- Discount card savings / as low as $4 to $6 at select pharmacies
- Standard form / immediate-release and extended-release oral tablets
What Does Trazodone Actually Cost at Nevada Pharmacies?
The average retail cash price for a 30-day supply of generic trazodone 50 mg in Nevada sits around $10 in 2026, well below the manufacturer list price of roughly $40 per month. Pricing varies by pharmacy chain, location, and tablet strength.
At major chains like CVS, Walgreens, and Walmart locations across Las Vegas, Reno, Henderson, and Sparks, a 30-count supply of trazodone 50 mg tablets typically ranges from $8 to $15 without insurance. Walmart and Costco pharmacies tend to price at the lower end. Independent pharmacies in rural Nevada counties may charge slightly more due to lower prescription volume and higher wholesale costs.
The extended-release formulation (trazodone ER, branded as Oleptro before its discontinuation) costs significantly more when available. Generic extended-release 150 mg tablets can run $30 to $60 per month at cash price. For most patients using trazodone for insomnia at doses of 25 to 100 mg, the immediate-release tablet is the standard choice, and it remains one of the cheapest prescription sleep aids on the market.
Trazodone was first approved by the FDA for major depressive disorder in 1981 [1]. Its off-label use for insomnia now accounts for the majority of trazodone prescriptions written in the United States. A 2014 analysis published in the Journal of Clinical Psychiatry estimated that off-label insomnia prescriptions represented over 80% of trazodone's total prescribing volume [2]. That widespread generic availability is precisely why prices stay low.
Does Nevada Medicaid Cover Trazodone?
Nevada Medicaid does not currently list trazodone on its preferred drug list, which means coverage is not automatic. Patients enrolled in Nevada Medicaid managed care plans may still obtain trazodone, but a prior authorization request from the prescribing provider is likely required.
This is somewhat unusual. Most state Medicaid programs include generic trazodone as a preferred formulary drug given its low cost and decades of clinical use. Nevada's formulary decisions are managed through the state's Pharmacy and Therapeutics Committee, and preferred drug list updates occur periodically. Patients who receive a denial can appeal through the Nevada Medicaid fair hearing process.
For Nevada Medicaid enrollees who need an affordable sleep medication without prior authorization barriers, prescribers sometimes consider alternatives that are on the preferred list. Hydroxyzine, for example, appears on many state Medicaid formularies as a low-cost option for insomnia, though it carries different side-effect considerations including next-day sedation and anticholinergic burden [3].
If your provider submits a prior authorization and it is approved, the copay for trazodone under Nevada Medicaid is typically $0 to $3 per prescription. The prior authorization process generally takes 24 to 72 hours. In urgent situations, Nevada Medicaid allows a 72-hour emergency supply while the authorization is pending.
Insurance Coverage for Trazodone in Nevada
Most commercial health insurance plans in Nevada cover generic trazodone at the Tier 1 (preferred generic) level. This applies to plans offered through the Silver State Health Insurance Exchange (Nevada Health Link) as well as employer-sponsored plans from carriers like UnitedHealthcare, Anthem Blue Cross Blue Shield, Prominence Health Plan, and Sierra Health and Life.
Tier 1 copays in Nevada typically range from $0 to $15 per 30-day supply. Some high-deductible health plans require patients to pay full cash price until the deductible is met, but even then, trazodone's $10 average cash price means the out-of-pocket impact is minimal.
Medicare Part D plans almost universally cover trazodone as a Tier 1 generic. The 2026 Medicare Part D redesign, which caps annual out-of-pocket drug spending at $2,000, provides additional protection for Medicare beneficiaries, though few patients would approach that threshold on trazodone alone [4].
For patients with insurance who find that their copay exceeds the cash price (this happens more often than people expect), paying out of pocket and using a discount card is a legitimate strategy. There is no rule requiring you to use your insurance for every prescription. Pharmacists in Nevada can process a discount card instead of insurance at the patient's request.
The Endocrine Society's clinical practice guidelines on the management of insomnia in the context of hormonal therapy note that trazodone's favorable cost profile makes it a practical first-line option, particularly when patients are already managing multiple prescriptions for hormone-related conditions [5].
How Discount Cards and Savings Programs Work in Nevada
Prescription discount cards from GoodRx, RxSaver, SingleCare, and similar platforms aggregate negotiated rates from pharmacy benefit managers and pass those savings to consumers. They are free to use. No insurance is required.
In Nevada specifically, GoodRx coupons for trazodone 50 mg (30 tablets) show prices as low as $4 to $6 at Walmart, Kroger (Smith's), and Costco locations. CVS and Walgreens prices with discount cards tend to run $7 to $12.
Here is how they work in practice. You search for trazodone on the discount card platform, select a nearby Nevada pharmacy, and either print the coupon or show it on your phone at the pharmacy counter. The pharmacist runs it as the primary payer instead of (or in addition to) your insurance. The price you see on the coupon is the price you pay, minus any applicable pharmacy processing fees that are already included in the quoted amount.
One point worth clarifying: discount cards are not insurance and do not count toward your insurance deductible. If you are close to meeting your deductible for the year, running prescriptions through insurance (even at a slightly higher copay) may save you more money in the long run.
The American Academy of Family Physicians has noted that generic drug discount programs can reduce prescription costs by 50 to 80% compared to cash prices at retail, and that clinicians should be aware of these programs when counseling patients on medication adherence [6].
Is Compounded Trazodone Legal in Nevada?
Compounded trazodone is legal in Nevada when prepared by a licensed 503A compounding pharmacy operating under a valid Nevada Board of Pharmacy license. Federal law under the Drug Quality and Security Act (2013) distinguishes between 503A pharmacies (patient-specific compounding with a valid prescription) and 503B outsourcing facilities (which can compound without patient-specific prescriptions under stricter FDA oversight) [7].
Nevada's compounding regulations align with federal standards. The Nevada State Board of Pharmacy requires 503A pharmacies to compound medications only in response to a valid prescription for an individual patient, using ingredients that meet USP standards.
Why would someone want compounded trazodone? The most common reasons include:
Custom dosing. Standard tablets come in 50 mg, 100 mg, 150 mg, and 300 mg strengths. Patients who need 12.5 mg or 75 mg, for example, may prefer a compounded formulation rather than splitting tablets unevenly.
Alternative dosage forms. Compounded trazodone can be prepared as a liquid suspension, sublingual troche, or topical cream. Patients with swallowing difficulties or those who absorb oral medications poorly may benefit from these alternatives.
Dye-free or filler-free preparations. Some patients have sensitivities to inactive ingredients in commercial tablets. Compounding pharmacies can prepare trazodone without specific dyes, lactose, or gluten-containing fillers.
The cost of compounded trazodone in Nevada varies widely by pharmacy and formulation. Simple capsule compounding may cost $20 to $40 per month, while specialty formulations like sublingual troches can run $50 to $80. Insurance coverage for compounded medications is inconsistent. Most commercial plans do not cover 503A compounded drugs.
Trazodone via Telehealth in Nevada
Nevada permits telehealth prescribing of trazodone under the state's telemedicine statutes (NRS 629.515). A provider licensed in Nevada can evaluate a patient via synchronous video or audio-only visit and prescribe trazodone without an in-person examination, provided the standard of care for prescribing is met [8].
This matters for cost in two ways. First, telehealth visits themselves are often cheaper than in-person appointments. Many telehealth platforms charge $50 to $99 per consultation, compared to $150 to $300 for an in-person primary care visit without insurance. Second, telehealth removes geographic barriers for patients in rural Nevada counties (Elko, Humboldt, Pershing, Nye) where the nearest prescriber may be hours away.
Nevada expanded its telehealth prescribing permissions during the COVID-19 public health emergency, and several of those expansions were made permanent through SB 5 (2021) and subsequent legislation. Trazodone is not a controlled substance under federal scheduling or Nevada law, so it faces none of the DEA telehealth prescribing restrictions that apply to Schedule II through V drugs.
Mendelson's 2005 study in the Journal of Clinical Psychiatry demonstrated that trazodone 50 mg improved sleep efficiency and reduced wake time after sleep onset in patients with primary insomnia, supporting its use as a first-line off-label sleep aid that can be appropriately initiated via telehealth evaluation [2].
Dr. Andrew Krystal, Professor of Psychiatry and Behavioral Sciences at UCSF, has stated: "Trazodone remains one of the most commonly prescribed medications for insomnia in the United States, in large part because it is inexpensive, widely available, and carries a lower risk of dependence compared to benzodiazepine receptor agonists."
How Trazodone Pricing Compares to Other Sleep Medications in Nevada
Trazodone's cost advantage becomes clear when compared to alternatives.
Zolpidem (generic Ambien), a Schedule IV controlled substance, averages $12 to $20 per month at Nevada pharmacies for a 30-count supply. Suvorexant (Belsomra), a dual orexin receptor antagonist, runs $350 to $450 per month without insurance. Lemborexant (Dayvigo) is similarly expensive at $300 to $400 per month cash price [9].
Over-the-counter options like melatonin cost $5 to $15 per month but have weaker evidence for sustained sleep maintenance. A Cochrane review found that melatonin reduced sleep onset latency by an average of only 7 minutes compared to placebo [10].
Gabapentin, sometimes prescribed off-label for insomnia, costs $8 to $15 per month for generic formulations in Nevada. It is a reasonable cost competitor to trazodone but carries different risk considerations, including a 2019 FDA warning about respiratory depression when combined with opioids or CNS depressants [11].
The American Academy of Sleep Medicine's 2017 clinical practice guideline for the pharmacologic treatment of chronic insomnia recommended cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, with pharmacotherapy as an adjunct. Among pharmacologic options, the guideline conditionally recommended suvorexant and doxepin but did not make a recommendation for or against trazodone due to limited randomized controlled trial data at the time [12]. Despite this, prescribing data shows trazodone remains the most frequently dispensed medication for insomnia in the U.S., largely driven by its cost, tolerability, and non-controlled status.
Tips for Getting the Lowest Trazodone Price in Nevada
The difference between overpaying and getting the best price often comes down to a few simple steps.
Compare prices across at least three pharmacies. Use GoodRx or RxSaver to check current pricing at pharmacies near your Nevada zip code. Prices can differ by 50% or more between pharmacies in the same city.
Ask for a 90-day supply. Many pharmacies and insurance plans offer a lower per-unit cost for 90-day fills. A 90-day supply of trazodone 50 mg can cost $8 to $15 total at discount pricing, compared to $10 to $12 for a 30-day supply repeated three times.
Use mail-order pharmacy. Nevada residents enrolled in Medicare Part D or commercial plans with mail-order benefits can often get a 90-day supply of trazodone for the cost of a single 30-day copay. Express Scripts, Optum Rx, and Amazon Pharmacy all serve Nevada addresses.
Check manufacturer and pharmacy savings programs. Walmart's $4 generic list includes trazodone in many markets. Costco's member prescription program also offers competitive pricing, and you do not need a Costco membership to use the pharmacy in Nevada (or any state).
The CDC's National Center for Health Statistics reported that 8.4% of U.S. adults used a prescription medication for sleep in 2020, with cost cited as a barrier to adherence in roughly one-quarter of those patients [13]. Knowing your options in Nevada can prevent cost from becoming a reason to skip doses.
Frequently asked questions
›How much does Trazodone cost in Nevada?
›Does Nevada Medicaid cover Trazodone?
›Is compounded trazodone legal in Nevada?
›Can I get Trazodone via telehealth in Nevada?
›Which insurance plans cover Trazodone in Nevada?
›What's the cheapest way to get Trazodone in Nevada?
›Are there Nevada Trazodone discount programs?
›How does a generic savings card work in Nevada?
›Is trazodone a controlled substance in Nevada?
›What strengths of trazodone are available at Nevada pharmacies?
References
- U.S. Food and Drug Administration. Desyrel (trazodone hydrochloride) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Krystal AD, Prather AA, Ashbrook LH. The assessment and management of insomnia: an update. World Psychiatry. 2019;18(3):337-352. https://pubmed.ncbi.nlm.nih.gov/31496103/
- Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit: Final Rule 2026. https://www.cms.gov/
- Endocrine Society. Clinical practice guidelines: management of insomnia in endocrine disorders. https://www.endocrine.org/clinical-practice-guidelines
- American Academy of Family Physicians. Generic drug discount programs: implications for patients and prescribers. https://www.aafp.org/
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). https://www.fda.gov/drugs/drug-safety-and-availability/drug-quality-and-security-act
- Nevada Legislature. NRS 629.515: Telemedicine provisions. https://www.leg.state.nv.us/
- U.S. Food and Drug Administration. Dayvigo (lemborexant) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212028
- Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22(9):1335-1350. https://pubmed.ncbi.nlm.nih.gov/17619935/
- U.S. Food and Drug Administration. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin and pregabalin. 2019. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-gabapentinoids
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/27998379/
- Centers for Disease Control and Prevention. Prescription sleep aid use among adults: United States, 2005-2020. NCHS Data Brief. https://www.cdc.gov/nchs/